Current Pharmaceutical Design
Title: Editorial [ Ground-Breaking Mathematical Models for Basic and Applied Research Executive Editors: A.O. Vassilev and H.E. Tibbles ]Part-II
Volume: 13 Issue: 15
Author(s): Heather E. Tibbles and Alexei O. Vassilev
Affiliation:
Export Options
About this article
Cite this article as:
Tibbles E. Heather and Vassilev O. Alexei, Editorial [ Ground-Breaking Mathematical Models for Basic and Applied Research Executive Editors: A.O. Vassilev and H.E. Tibbles ]Part-II, Current Pharmaceutical Design 2007; 13 (15) . https://dx.doi.org/10.2174/138161207780765855
DOI https://dx.doi.org/10.2174/138161207780765855 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis, Selective Cancer Cytotoxicity and Mechanistic Studies of Novel Analogs of Lantadenes
Anti-Cancer Agents in Medicinal Chemistry Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Current Drug Targets MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics
Current Medicinal Chemistry Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling
Current Cancer Drug Targets A Fresh Prospect of Extracellular Matrix Hydrolytic Enzymes and Their Substrates
Current Pharmaceutical Design Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine Withdrawal Notice: Role of MicroRNAs (224 and 96) as Novel Biomarkers for Hepatocellular Carcinoma
Current Cancer Therapy Reviews The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Identification of a RhoA- and SRF-Dependent Mechanism of Androgen Action that is Associated with Prostate Cancer Progression
Current Drug Targets The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease
Current Pharmaceutical Design Biomedical Imaging in Implantable Drug Delivery Systems
Current Drug Targets Nanoemulsions for Improved Efficacy of Phytotherapeutics- A Patent Perspective
Recent Patents on Nanotechnology Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry Matrix Metalloproteinases
Current Medicinal Chemistry Is Type 2 Diabetes Mellitus a Predisposal Cause for Developing Hepatocellular Carcinoma?
Current Diabetes Reviews Meet Our Editorial Board Member:
Current Medicinal Chemistry Recent Mass Spectrometric Based Methods in Quantitative N-linked Glycoproteomics
Current Proteomics Therapeutic Potential of Targeting PAK Signaling
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Genetic Therapy for Fanconi Anemia – A New Hope
Current Gene Therapy